Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype‐4 chronic hepatitis C patients

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 88, Iss. 12, 2016-12 ,pp. : 2170-2178

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma—A retrospective multicenter study

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 7, 2015-07 ,pp. : 1199-1206

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin D‐related gene polymorphisms do not influence the outcome and serum vitamin D level in pegylated interferon/ribavirin therapy combined with protease inhibitor for patients with genotype 1b chronic hepatitis C

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 11, 2015-11 ,pp. : 1904-1912

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic Variants in the Apoptosis Gene BCL2L1 Improve Response to Interferon-Based Treatment of Hepatitis C Virus Genotype 3 Infection

By Clausen Louise Nygaard   Weis Nina   Ladelund Steen   Madsen Lone   Lunding Suzanne   Tarp Britta   Christensen Peer Brehm   Krarup Henrik Bygum   Møller Axel   Gerstoft Jan   Clausen Mette Rye   Benfield Thomas   Mobasheri Ali  

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-02 ,pp. : 3213-3225

MDPI

Access to resources Recommend Favorite

Hepatitis C virus genotype 4 in England: Diversity and demographic associations

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 3, 2015-03 ,pp. : 417-423

John Wiley & Sons Inc

Access to resources Recommend Favorite